News from us and our partners

Tags

Topics

0 results

News
4 April, 2016
Flexion Therapeutics Announces Presentation of Results From Pivotal Phase 2b and Phase 3 Clinical Trials for Zilretta™ at Osteoarthritis Research Society International (OARSI) 2016 World Congress
News
17 March, 2016
Gecko Biomedical raises €22.5 million led by Sofinnova Partners
News
15 March, 2016
BASF and Avantium intend to establish joint venture
News
9 March, 2016
CelluComp Completes £3.7 Million Financing
News
24 February, 2016
World Premiere - Pixium Vision implants IRIS® II, first epi-retinal implant with 150 electrodes
News
23 February, 2016
ReCor Medical Announces IDE Approval for RADIANCE-HTN Hypertension Clinical Trial
News
18 February, 2016
Corvidia Therapeutics Raises $26M in a Series A Financing, Led by Sofinnova Partners and Apple Tree Partners
News
17 February, 2016
Comet Biorefining to build first commercial cellulosic sugar plant
News
3 February, 2016
Sofinnova Partners leads Enyo Pharma €22M financing
News
2 February, 2016
Mission Therapeutics raises £60 million to progress
News
18 January, 2016
Bioamber Inc. announces pricing of $13.0 million public offering
News
8 December, 2015
Sofinnova Partners raises €300 million healthcare fund
News
4 December, 2015
Additional Data Confirm Positive Results for Clinical Trial of ReActiv8®
News
26 November, 2015
TWB announces the creation of EnobraQ, specialist in CO2 capture and exploitation using yeast
News
24 November, 2015
Lysogene Receives Orphan Drug Designation and Rare Pediatric Disease Designation from the FDA
News
23 November, 2015
ObsEva Closes CHF 60 (USD 60) Million in Series B Financing

Flexion Therapeutics Announces Presentation of Results From Pivotal Phase 2b and Phase 3 Clinical Trials for Zilretta™ at Osteoarthritis Research Society International (OARSI) 2016 World Congress

Gecko Biomedical raises €22.5 million led by Sofinnova Partners

BASF and Avantium intend to establish joint venture

CelluComp Completes £3.7 Million Financing

World Premiere - Pixium Vision implants IRIS® II, first epi-retinal implant with 150 electrodes

ReCor Medical Announces IDE Approval for RADIANCE-HTN Hypertension Clinical Trial

Corvidia Therapeutics Raises $26M in a Series A Financing, Led by Sofinnova Partners and Apple Tree Partners

Comet Biorefining to build first commercial cellulosic sugar plant

Sofinnova Partners leads Enyo Pharma €22M financing

Mission Therapeutics raises £60 million to progress

Bioamber Inc. announces pricing of $13.0 million public offering

Sofinnova Partners raises €300 million healthcare fund

Additional Data Confirm Positive Results for Clinical Trial of ReActiv8®

TWB announces the creation of EnobraQ, specialist in CO2 capture and exploitation using yeast

Lysogene Receives Orphan Drug Designation and Rare Pediatric Disease Designation from the FDA

ObsEva Closes CHF 60 (USD 60) Million in Series B Financing